Eyewire News: The Podcast

Outlook Wins Appeal for Wet AMD Drug Candidate Lytenava

4 min · 27. Mai 2026
Episode Outlook Wins Appeal for Wet AMD Drug Candidate Lytenava Cover

Beschreibung

Outlook Therapeutics takes a major step forward in its plan to gain approval for wet AMD drug Lytenava; the first commercial FLIGHT procedures using the ViaLuxe Laser System are performed in Europe; and Oculus introduces a new AI-assisted tool designed to help clinicians evaluate MGD using meibography images. Learn more about your ad choices. Visit megaphone.fm/adchoices [https://megaphone.fm/adchoices]

Kommentare

0

Sei die erste Person, die kommentiert

Melde dich jetzt an und werde Teil der Eyewire News: The Podcast-Community!

Loslegen

2 Monate für 1 €

Dann 4,99 € / Monat · Jederzeit kündbar

  • Podcasts nur bei Podimo
  • 20 Stunden Hörbücher / Monat
  • Alle kostenlosen Podcasts

Alle Folgen

101 Folgen